Rockefeller Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-300
| Closed | -$3K | – | 2663 |
|
|
2022
Q4 | $3K | Sell |
300
-680
| -69% | -$6.8K | ﹤0.01% | 3460 |
|
|
2022
Q3 | $10K | Sell |
980
-146
| -13% | -$1.49K | ﹤0.01% | 3082 |
|
|
2022
Q2 | $12K | Sell |
1,126
-268
| -19% | -$2.86K | ﹤0.01% | 3009 |
|
|
2022
Q1 | $13K | Sell |
1,394
-755
| -35% | -$7.04K | ﹤0.01% | 2913 |
|
|
2021
Q4 | $24K | Buy |
2,149
+1,004
| +88% | +$11.2K | ﹤0.01% | 2558 |
|
|
2021
Q3 | $10K | Sell |
1,145
-69
| -6% | -$603 | ﹤0.01% | 2887 |
|
|
2021
Q2 | $11K | Buy |
1,214
+1,049
| +636% | +$9.51K | ﹤0.01% | 2738 |
|
|
2021
Q1 | $1K | Sell |
165
-883
| -84% | -$5.35K | ﹤0.01% | 3172 |
|
|
2020
Q4 | $24K | Sell |
1,048
-9,191
| -90% | -$210K | ﹤0.01% | 1931 |
|
|
2020
Q3 | $143K | Buy |
10,239
+858
| +9% | +$12K | ﹤0.01% | 1151 |
|
|
2020
Q2 | $142K | Sell |
9,381
-33
| -0.4% | -$500 | ﹤0.01% | 1050 |
|
|
2020
Q1 | $87K | Sell |
9,414
-3,086
| -25% | -$28.5K | ﹤0.01% | 1057 |
|
|
2019
Q4 | $122K | Sell |
12,500
-2,050
| -14% | -$20K | ﹤0.01% | 910 |
|
|
2019
Q3 | $117K | Buy |
14,550
+2,992
| +26% | +$24.1K | ﹤0.01% | 747 |
|
|
2019
Q2 | $144K | Buy |
11,558
+11,495
| +18,246% | +$143K | ﹤0.01% | 632 |
|
|
2019
Q1 | $1K | Buy |
+63
| New | +$1K | ﹤0.01% | 1852 |
|
|
2018
Q3 | – | Sell |
-19,169
| Closed | -$299K | – | 767 |
|
|
2018
Q2 | $299K | Hold |
19,169
| – | – | ﹤0.01% | 304 |
|
|
2018
Q1 | $288K | Buy |
+19,169
| New | +$288K | ﹤0.01% | 305 |
|